100 related articles for article (PubMed ID: 25251606)
21. Pulmonary delivery of recombinant acid sphingomyelinase improves clearance of lysosomal sphingomyelin from the lungs of a murine model of Niemann-Pick disease.
Ziegler RJ; Brown C; Barbon CM; D'Angona AM; Schuchman EH; Andrews L; Thurberg BL; McPherson JM; Karey KP; Cheng SH
Mol Genet Metab; 2009 May; 97(1):35-42. PubMed ID: 19231265
[TBL] [Abstract][Full Text] [Related]
22. Hematopoietic stem cell gene therapy leads to marked visceral organ improvements and a delayed onset of neurological abnormalities in the acid sphingomyelinase deficient mouse model of Niemann-Pick disease.
Miranda SR; Erlich S; Friedrich VL; Gatt S; Schuchman EH
Gene Ther; 2000 Oct; 7(20):1768-76. PubMed ID: 11083499
[TBL] [Abstract][Full Text] [Related]
23. Massive Accumulation of Sphingomyelin Affects the Lysosomal and Mitochondria Compartments and Promotes Apoptosis in Niemann-Pick Disease Type A.
Carsana EV; Lunghi G; Prioni S; Mauri L; Loberto N; Prinetti A; Zucca FA; Bassi R; Sonnino S; Chiricozzi E; Duga S; Straniero L; Asselta R; Soldà G; Samarani M; Aureli M
J Mol Neurosci; 2022 Jul; 72(7):1482-1499. PubMed ID: 35727525
[TBL] [Abstract][Full Text] [Related]
24. Lipid-induced lysosomal damage after demyelination corrupts microglia protective function in lysosomal storage disorders.
Gabandé-Rodríguez E; Pérez-Cañamás A; Soto-Huelin B; Mitroi DN; Sánchez-Redondo S; Martínez-Sáez E; Venero C; Peinado H; Ledesma MD
EMBO J; 2019 Jan; 38(2):. PubMed ID: 30530526
[TBL] [Abstract][Full Text] [Related]
25. Apolipoprotein D-mediated preservation of lysosomal function promotes cell survival and delays motor impairment in Niemann-Pick type A disease.
Pascua-Maestro R; Corraliza-Gomez M; Fadrique-Rojo C; Ledesma MD; Schuchman EH; Sanchez D; Ganfornina MD
Neurobiol Dis; 2020 Oct; 144():105046. PubMed ID: 32798728
[TBL] [Abstract][Full Text] [Related]
26. Intracerebral transplantation of adult mouse neural progenitor cells into the Niemann-Pick-A mouse leads to a marked decrease in lysosomal storage pathology.
Shihabuddin LS; Numan S; Huff MR; Dodge JC; Clarke J; Macauley SL; Yang W; Taksir TV; Parsons G; Passini MA; Gage FH; Stewart GR
J Neurosci; 2004 Nov; 24(47):10642-51. PubMed ID: 15564580
[TBL] [Abstract][Full Text] [Related]
27. Alveolar lipoproteinosis in an acid sphingomyelinase-deficient mouse model of Niemann-Pick disease.
Ikegami M; Dhami R; Schuchman EH
Am J Physiol Lung Cell Mol Physiol; 2003 Mar; 284(3):L518-25. PubMed ID: 12495943
[TBL] [Abstract][Full Text] [Related]
28. Neuropathological changes in the peripheral nervous system and spinal cord in a transgenic mouse model of Niemann-Pick disease type A.
Marmiroli P; Rodriguez-Menendez V; Rigamonti L; Tonoli E; Rigolio R; Cavaletti G; Tredici G; Vercelli A
Clin Neuropathol; 2009; 28(4):263-74. PubMed ID: 19642505
[TBL] [Abstract][Full Text] [Related]
29. [Advances in molecular genetics of the Niemann-Pick group of diseases].
Ohno K
Nihon Rinsho; 1993 Sep; 51(9):2293-9. PubMed ID: 8411705
[TBL] [Abstract][Full Text] [Related]
30. Characterization of common SMPD1 mutations causing types A and B Niemann-Pick disease and generation of mutation-specific mouse models.
Jones I; He X; Katouzian F; Darroch PI; Schuchman EH
Mol Genet Metab; 2008 Nov; 95(3):152-62. PubMed ID: 18815062
[TBL] [Abstract][Full Text] [Related]
31. Adeno-associated viral vector serotype 9-based gene therapy for Niemann-Pick disease type A.
Samaranch L; Pérez-Cañamás A; Soto-Huelin B; Sudhakar V; Jurado-Arjona J; Hadaczek P; Ávila J; Bringas JR; Casas J; Chen H; He X; Schuchman EH; Cheng SH; Forsayeth J; Bankiewicz KS; Ledesma MD
Sci Transl Med; 2019 Aug; 11(506):. PubMed ID: 31434754
[TBL] [Abstract][Full Text] [Related]
32. Acid sphingomyelinase deficient mice: a model of types A and B Niemann-Pick disease.
Horinouchi K; Erlich S; Perl DP; Ferlinz K; Bisgaier CL; Sandhoff K; Desnick RJ; Stewart CL; Schuchman EH
Nat Genet; 1995 Jul; 10(3):288-93. PubMed ID: 7670466
[TBL] [Abstract][Full Text] [Related]
33. Anomalous surface distribution of glycosyl phosphatidyl inositol-anchored proteins in neurons lacking acid sphingomyelinase.
Galvan C; Camoletto PG; Cristofani F; Van Veldhoven PP; Ledesma MD
Mol Biol Cell; 2008 Feb; 19(2):509-22. PubMed ID: 18032586
[TBL] [Abstract][Full Text] [Related]
34. Altered Macrophage Function Associated with Crystalline Lung Inflammation in Acid Sphingomyelinase Deficiency.
Poczobutt JM; Mikosz AM; Poirier C; Beatman EL; Serban KA; Gally F; Cao D; McCubbrey AL; Cornell CF; Schweitzer KS; Berdyshev EV; Bronova IA; Paris F; Petrache I
Am J Respir Cell Mol Biol; 2021 May; 64(5):629-640. PubMed ID: 33662226
[TBL] [Abstract][Full Text] [Related]
35. Merits of combination cortical, subcortical, and cerebellar injections for the treatment of Niemann-Pick disease type A.
Bu J; Ashe KM; Bringas J; Marshall J; Dodge JC; Cabrera-Salazar MA; Forsayeth J; Schuchman EH; Bankiewicz KS; Cheng SH; Shihabuddin LS; Passini MA
Mol Ther; 2012 Oct; 20(10):1893-901. PubMed ID: 22828503
[TBL] [Abstract][Full Text] [Related]
36. Niemann-Pick type C disease: novel NPC1 mutations and characterization of the concomitant acid sphingomyelinase deficiency.
Tamura H; Takahashi T; Ban N; Torisu H; Ninomiya H; Takada G; Inagaki N
Mol Genet Metab; 2006 Feb; 87(2):113-21. PubMed ID: 16143556
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of fatty acid amide hydrolase prevents pathology in neurovisceral acid sphingomyelinase deficiency by rescuing defective endocannabinoid signaling.
Bartoll A; Toledano-Zaragoza A; Casas J; Guzmán M; Schuchman EH; Ledesma MD
EMBO Mol Med; 2020 Nov; 12(11):e11776. PubMed ID: 33016621
[TBL] [Abstract][Full Text] [Related]
38. Ellagic acid and its metabolites urolithins A/B ameliorate most common disease phenotypes in cellular and mouse models for lysosomal storage disorders by enhancing extracellular vesicle secretion.
Soto-Huelin B; Babiy B; Pastor O; Díaz-García M; Toledano-Zaragoza A; Frutos MD; Espín JC; Tomás-Barberán FA; Busto R; Ledesma MD
Neurobiol Dis; 2023 Jun; 182():106141. PubMed ID: 37121555
[TBL] [Abstract][Full Text] [Related]
39. Modulation of Dietary Choline Uptake in a Mouse Model of Acid Sphingomyelinase Deficiency.
Gaudioso Á; Moreno-Huguet P; Casas J; Schuchman EH; Ledesma MD
Int J Mol Sci; 2023 Jun; 24(11):. PubMed ID: 37298714
[TBL] [Abstract][Full Text] [Related]
40. Niemann-Pick Type A Disease: Behavior of Neutral Sphingomyelinase and Vitamin D Receptor.
Conte C; Arcuri C; Cataldi S; Mecca C; Codini M; Ceccarini MR; Patria FF; Beccari T; Albi E
Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31086057
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
